Docetaxel, cisplatin and fluorouracil combination in the neoadjuvant treatment of locally advanced gastric adenocarcinoma : Phase II clinical study

Trial Profile

Docetaxel, cisplatin and fluorouracil combination in the neoadjuvant treatment of locally advanced gastric adenocarcinoma : Phase II clinical study

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2015

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Acronyms Neotax
  • Sponsors Sanofi
  • Most Recent Events

    • 02 Apr 2012 Actual patient number 59 added as reported by ClinicalTrials.gov.
    • 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top